Search Results - "Collins, Christopher E"
-
1
The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus
Published in PloS one (16-02-2010)“…Excessive activity of dendritic cells (DCs) is postulated as a central disease mechanism in Systemic Lupus Erythematosus (SLE). Vitamin D is known to reduce…”
Get full text
Journal Article -
2
Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study
Published in Arthritis research & therapy (01-01-2009)“…TNF-like weak inducer of apoptosis (TWEAK) has been implicated as a mediator of chronic inflammatory processes via prolonged activation of the NF-kappaB…”
Get full text
Journal Article -
3
A Multianalyte Assay Panel With Cell‐Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology–Classified Lupus
Published in ACR open rheumatology (01-02-2021)“…Objective To evaluate the usefulness of biomarkers to predict the evolution of patients suspected of systemic lupus erythematosus (SLE), designated as probable…”
Get full text
Journal Article -
4
Baricitinib, a Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials
Published in Clinical rheumatology (01-10-2018)“…Janus kinases (JAKs) play an important role in intracellular signaling for multiple cytokines in the pathogenesis of RA. Baricitinib is an oral, selective JAK…”
Get full text
Journal Article -
5
Cell-bound complement activation products associate with lupus severity in SLE
Published in Lupus science & medicine (05-05-2020)“…ObjectivesTo evaluate the association between lupus severity and cell-bound complement activation products (CB-CAPs) or low complement proteins C3 and…”
Get full text
Journal Article -
6
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology–Classified Systemic Lupus Erythematosus
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-01-2020)“…Objective To evaluate the frequency of cell‐bound complement activation products (CB‐CAPs) as a marker of complement activation in patients with suspected…”
Get full text
Journal Article -
7
Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies
Published in Rheumatology and therapy. (01-12-2020)“…Introduction The real-world effectiveness of belimumab for systemic lupus erythematosus (SLE) in six countries was evaluated in the OBSErve program. The aim of…”
Get full text
Journal Article -
8
Calcium and vitamin D supplementation and incident rheumatoid arthritis: the Women’s Health Initiative Calcium plus Vitamin D trial
Published in Rheumatology international (01-12-2012)Get full text
Journal Article -
9
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels
Published in Arthritis research & therapy (01-01-2006)“…Considerable evidence points to a role for B lymphocyte stimulator (BLyS) overproduction in murine and human systemic lupus erythematosus (SLE). Nevertheless,…”
Get full text
Journal Article -
10
Calcium and vitamin D supplementation and incident rheumatoid arthritis: the Women’s Health Initiative Calcium plus Vitamin D trial
Published in Rheumatology international (01-12-2012)“…To determine whether calcium plus vitamin D supplementation (CaD) affects incidence of rheumatoid arthritis (RA). Participants enrolled in the Women’s Health…”
Get full text
Journal Article -
11
70 years of progress: history of the Rheumatism Society of the District of Columbia, 1946–2016
Published in International journal of rheumatic diseases (01-12-2017)Get full text
Journal Article -
12
Pulmonary involvement in microscopic polyangiitis
Published in Current opinion in pulmonary medicine (01-09-2005)“…PURPOSE OF REVIEWMicroscopic polyangiitis is a systemic necrotizing vasculitis that affects small vessels, resulting in a wide spectrum of organ involvement…”
Get full text
Journal Article -
13
Long-Term Safety and Efficacy of Voclosporin in Patients With Lupus Nephritis and Low eGFR: TH-PO488
Published in Journal of the American Society of Nephrology (01-11-2022)Get full text
Journal Article -
14
Winners of the 2020 American College of Rheumatology Annual Image Competition
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-01-2021)Get full text
Journal Article -
15
Winners of the 2018 and 2019 American College of Rheumatology Annual Image Competition
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2019)Get full text
Journal Article -
16
Cell bound complement activation products alone and in combination with low serum complement C3 or C4 have superior diagnostic performance in systemic lupus erythematosus
Published in The Journal of immunology (1950) (01-05-2019)“…Abstract BACKGROUND Cell-bound complement activation products (CB-CAPs) are sensitive and specific diagnostic markers of systemic lupus erythematosus (SLE). We…”
Get full text
Journal Article